Keywords: Lantio Pharma, Tarix Pharma, Lung injury, Lanthione peptides, PanCyte

Lanthio Pharma licenses drug to Tarix

Article | 21 February 2012

Lanthio Pharma, a privately-held Dutch peptide drug company, says that it has granted USA-based Tarix Pharmaceuticals exclusive license to its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Lanthio Pharma

Tarix Pharmaceuticals

Go to company listing